Health Payer Intelligence February 5, 2020
The changes would adjust Medicare Advantage star ratings and mandate that Part D plans develop an online price comparison tool to address prescription drug pricing.
CMS has proposed changes to Medicare Advantage that will increase plans’ revenues by 0.93 percent. The proposed rule would extend Medicare Advantage eligibility to those diagnosed with end-stage renal disease (ESRD), lower cost-sharing on prescription drugs, and enforce greater transparency and comparability of out-of-pocket healthcare spending for different drugs. CMS also introduced measures to promote using generics and biosimilars.
“Whether you’re a senior dealing with kidney disease, living in a rural area, facing high costs because you need a specialty drug, or just want a better sense of what you’ll owe for prescription drugs, these...
Today's Sponsors
Today's Sponsor